Vicarious Surgical Inc (NASDAQ:RBOT) shares are trading lower by 20% to $0.29 during Tuesday’s session after the company announced a 1-for-30 reverse stock split of its Class A and Class B common ...

Vicarious Surgical, Inc. a blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one ...

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...

The December in-vivo lab builds on Vicarious Surgical’s disciplined, specification-driven development approach and reflects the company’s focus on minimizing technical risk through iterative testing, ...

Vicarious Surgical Inc. (RBOT) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates ...

Vicarious Surgical's Beta 2 system is complete, it's now working toward its next system, v1.0. In order to reduce cash burn, RBOT cut its workforce by 14 percent while cutting other costs. With the ...

The average one-year price target for Vicarious Surgical (NYSE:RBOT) has been revised to $5.10 / share. This is a decrease of 44.44% from the prior estimate of $9.18 dated December 3, 2025. The price ...

Vicarious Surgical inks a software execution partnership to streamline development, cut costs and improve predictability.

RBOT is trading near the bottom of its 52-week range and below its 200-day simple moving average. Price change The price of RBOT shares has decreased $0.17 since the market last closed. This is a 7.14 ...